Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shuai Shen
CD48 Is a Key Molecule of Immunomodulation Affecting Prognosis in Glioma
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Immunomodulation Is the Key to Cardiac Repair
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients
Cancer Research
Cancer Research
Oncology
EZH2 Overexpression Is Associated With Poor Prognosis in Patients With Glioma
Oncotarget
Oncology
Serpin Peptidase Inhibitor, Clade a Member 3 (SERPINA3), Is Overexpressed in Glioma and Associated With Poor Prognosis in Glioma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Decreased Expression of the SPOP Gene Is Associated With Poor Prognosis in Glioma
International Journal of Oncology
Cancer Research
Oncology
Epigenetic Silencing of KAZALD1 Confers a Better Prognosis and Is Associated With Malignant Transformation/Progression in Glioma
Oncology Reports
Medicine
Cancer Research
Oncology
Exosomal microRNA‑210 Is a Potentially Non‑invasive Biomarker for the Diagnosis and Prognosis of Glioma
Oncology Letters
Cancer Research
Oncology
IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?
Oncologist
Cancer Research
Medicine
Oncology
Nuclear FABP7 Immunoreactivity Is Preferentially Expressed in Infiltrative Glioma and Is Associated With Poor Prognosis in EGFR-overexpressing Glioblastoma
BMC Cancer
Cancer Research
Oncology
Genetics
